pulmonary arterial hypertension
Conditions
Interventions
None listed
Sponsors
International University of Health and Welfare, Mita Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: PAH Patients who start ERA, PDE5i or sGC therapy newly
Exclusion criteria
Exclusion criteria: -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| onset of events comparison of treatments frequency of side effects | — |
Countries
Japan
Contacts
Public ContactYuichi Tamura
International University of Health and Welfare, Mita Hospital Cardiovascular internal medicine
Outcome results
None listed